MERIT Module: Starting people on GLP1 RA Therapy -
27th July 2021
This module covers all aspects surrounding
GLP1 RA therapy where it is appropriate.
healthcare professionals should feel
confident to consider GLP1 RA therapy treatment for their patients.
For booking or enquiries regarding any of the modules, please contact Kirsty Osborne
kobe@novonordisk.com Mobile 07818539378
The MERITTM
Programme for 2021 has been developed by Novo Nordisk.
The aim of the
programme is to support the development of skills and competency in the
management of Type 2 Diabetes in the primary care setting in line with TREND
competencies (https://diabetestimes.co.uk/wp-content/uploads/2019/03/Framework_5th_EDN_TREND.pdf).
What is the MERITTM programme?
MERIT™ (Meeting Educational Requirements
Improving Treatment) is a two-part flexible class-room based education programme
developed by Novo Nordisk. MERIT™ is a competency-based programme and is for
all healthcare professionals involved in diabetes care.
The programme will
combine the theory required to support diabetes management followed by the provision
of tailored clinical support from specialist diabetes teams. It is recommended that all healthcare colleagues
attend together to maximise learning opportunities back in practice.
How to book a place
The programme consists of 4 modules which can
be accessed individually or as a whole programme throughout the year. Bookings
can be made directly with the programme co-ordinator (details on page 2) on
receipt of this flyer to guarantee a place early.
Venues and timings for courses
All courses will
take place at Virtually via TEAMS unless otherwise stated.
Each part of the module completed will be
accredited with 2 CDP points .
THIS COURSE IS PROVIDED BY AN EXTERNAL PROVIDER. DEVON TRAINING HUB ARE NOT RESPONSIBLE FOR THIS COURSE.
